-
CluePoints Launches Complimentary COVID-19 Risk Management Package for Clinical Studies
Apr 6, 2020, 11:12 AM by Michael CroftKING OF PRUSSIA, PA, US - Apr 6, 2020 - CluePoints, the premier provider of Risk-Based Study Execution (RBx) and Data Quality Oversight Software for clinical trials, today announced that it has launched a complimentary COVID-19 risk management package available to all at no costFull story -
BioIVT Opens New Blood Donor Center to Support Boston-area Research into COVID-19 Therapies, Vaccines and Diagnostics
Apr 6, 2020, 08:13 AM by Michael CroftWESTBURY, NY - Apr 6, 2020 - BioIVT, a leading provider of research models and services for drug and diagnostic development, today announced the opening of its new blood donor center on the Tufts University campus in Medford, MA to support academic and pharmaceutical researchers involved in COVID-19, cell and gene therapy researchFull story -
AgileBio Launches a LIMS Package Addressed to COVID-19 Labs
Apr 3, 2020, 17:50 PM by Michael CroftSAN DIEGO, CA, US - Apr 3, 2020 - AgileBio, a leading global provider of LabCollector LIMS solution that enhances research, testing & traceability to scientist teams announces new COVID LabCollector + Lab Service Management (LSM) Pack that will increase the speed and efficiency in COVID-19 tests managementFull story -
Spring Bank Provides Update on Business Operations & Clinical Program Progress During COVID-19 Pandemic
Apr 3, 2020, 10:17 AM by Michael CroftHOPKINTON, MA, UNITED STATES - Apr 2, 2020 - Spring Bank Pharmaceuticals, Inc. (Nasdaq: SBPH), a clinical-stage biopharmaceutical company developing novel therapeutics for oncology and inflammatory diseases, today provided an update on the companys business operations in response to and as a result of the global COVID-19 pandemicFull story -
The American Hospital Association and AVIA Launch New Tool to Support Members on the Front Lines of the COVID-19 Crisis: Introducing the COVID-19 Digital Response Pulse
Apr 2, 2020, 10:18 AM by Michael CroftCHICAGO, IL, UNITED STATES - Apr 2, 2020 - Today, the American Hospital Association (AHA) & AVIA are reaching out to all AHA members with a new tool for rapid, critical support to deal with COVID-19Full story -
Seqster, Pryzm, Apple Tracking Symptoms, Spread, And Coronavirus Data
Apr 2, 2020, 09:40 AM by Michael CroftBio-IT World Last week, several groups released COVID-19 screening tools or symptom checkers to help track the spread of the virus, help people make decisions about when to receive care, and track trends. Apple and Seqster both launched symptom trackers in the United States. Covidaware.me launched internationally to track symptoms and share data, and the TwinsUK study launched a COVID-19 symptom tracker and research study using a cohort of twins.Full story -
AmoTx Now Offers Face Masks and PPE During Coronavirus Pandemic
Apr 2, 2020, 03:44 AM by Michael CroftNY, NY, UNITED STATES - Apr 2, 2020 - The medical device provider AmoTx is now openly offering face masks for people in Europe and North AmericaFull story -
InSysBio to announce the release of its new database Cytocon DB 1.1
Apr 1, 2020, 09:27 AM by Michael CroftMOSCOW, RUSSIA - Apr 1, 2020 - InSysBio, one of the worlds pioneers of Quantitative Systems Pharmacology (QSP) platform development and provision, has released its new Cytocon DB 1Full story -
PHARMASEAL Supports Life Science Businesses by Offering No Cost CTMS for COVID-19 Clinical Trials
Apr 1, 2020, 08:20 AM by Michael CroftNOTTINGHAM, UK - Apr 1, 2020 -Full storyPHARMASEAL Supports Life Science Businesses by Offering No Cost CTMS for COVID-19 Clinical TrialsNottingham, UK - 01 April 2020: PHARMASEAL International, provider of clinical trials management systems has today announced that it will offer the Engility® CTMS solution at no cost for COVID-19 Coronavirus clinical trialsx
-
Optibrium and Intellegens achieve further success in Open Source Malaria initiative with in vitro validation of in silico generated compound
Apr 1, 2020, 05:23 AM by Michael CroftCAMBRIDGE, UNITED KINGDOM - Apr 1, 2020 - Optibrium, leading providers of software and services for drug discovery, and Intellegens, a spin-out from the University of Cambridge with a unique Artificial Intelligence (AI) toolset, today announced they have reached a further significant milestone in their contribution to the Open Source Malaria (OSM) initiativeFull story -
Check4Cancer launches new London ‘OneStop Breast Clinic’ for younger patients who will no longer be seen in NHS breast clinics
Apr 1, 2020, 05:14 AM by Michael CroftLONDON, UK - Apr 1, 2020 - Professor Gordon Wishart, Chief Medical Officer of Check4Cancer, launches a private OneStop Breast Clinic for younger patients who will no longer be seen in NHS breast clinicsFull story -
Lifebit Provides Free Cloud Operating System, Data Hosting & Analysis Tools to COVID-19 Researchers
Mar 30, 2020, 12:46 PM by Michael CroftLONDON, UNITED KINGDOM - Mar 30, 2020 - Lifebit Biotech, a leading innovator in bioinformatics and cognitive software solutions, announced it is providing its premium Lifebit CloudOS license free to all researchers and teams working on COVID-19 efforts, including diagnostics, treatments, and vaccinesFull story -
Oxford Nanopore, Lifebit Biotech, Sinequa, And More: News From March 2020
Mar 30, 2020, 11:25 AM by Michael CroftFull storyBio-IT World March featured exciting new, products, and partnerships from around the bio-IT community from innovating companies, organizations, and universities, including Oxford Nanopore, Lifebit Biotech, Sinequa, and more.
-
New analysis confirms value of investing public money to commercialise public science
Mar 30, 2020, 06:24 AM by Michael CroftLONDON, UNITED KINGDOM - Mar 30, 2020 - The UK Innovation and Science Seed Fund (UKI2S) has published an independent economic analysis showing how its investment and continuing support have generated benefits for early stage companies and for the UK economy as a wholeFull story -
Real-time NAT enables remote COVID-19 testing
Mar 30, 2020, 00:09 AM by Michael CroftSYDNEY, AUSTRALIA - Mar 30, 2020 - Real-time NAT enables remote COVID-19 testingSydney, Australia, 30 March 2020: An Australian biotech has helped develop a mobile COVID-19 testing system that delivers highly accurate results within an hour, potentially slowing the spread of the virusFull story -
Microway Announces Delivery of Its Largest 2nd Gen AMD EPYC™ Processor-powered Cluster to Date
Mar 27, 2020, 14:36 PM by Michael CroftPLYMOUTH, MA, UNITED STATES - Mar 27, 2020 - Microway, a leading provider of computational clusters, servers, and workstations for AI and HPC applications, announces it has delivered a full-scale 2nd Gen AMD EPYC processor-powered cluster to a major insurance companyFull story -
New Virtual Reality Tool Simplifies Structure-Based Drug Design
Mar 27, 2020, 11:40 AM by Michael CroftFull storyBio-IT World | A virtual reality (VR) platform developed by researchers at the University of Bristol is allowing chemists, computational scientists and structural biologists to collaboratively design molecules like engineers create airplane components.
-
DermTech Announces Response to COVID-19
Mar 26, 2020, 12:45 PM by Michael CroftNEW YORK, NY, UNITED STATES - Mar 25, 2020 - DermTech, Inc. (NASDAQ: DMTK) (DermTech), a leader in precision dermatology enabled by a non-invasive skin genomics platform, today released the following letter from its CEO John Dobak, MFull story -
To Aid with COVID-19 Efforts, PhenoTips Offers Free Cloud-Hosted Genomics Software
Mar 24, 2020, 16:00 PM by Michael CroftTORONTO, ON, CANADA - Mar 24, 2020 - PhenoTips, a leading provider of precision medicine software, has announced their efforts to support genomic research during the COVID-19 pandemic in a blog post released on their websiteFull story -
Building A File System To Keep Up With Genomics England’s Five Million Genomes Project
Mar 24, 2020, 12:50 PM by Michael CroftFull storyBio-IT World When David Ardley took over the platforms function at Genomics England, he inherited “quite a challenging storage environment,” he told Bio-IT World. Genomics England expected to host over 140 petabytes of genomic data by 2023, and the current storage couldn't keep up. The group chose WekaIO to build the new storage environment.